Sign in
DGX-QUEST DIAGNOSTICS INC
Quest Diagnostics Achieves Strong Performance with 28.4% Share Growth and Zacks Rank #2 Amidst Competitive Market Challenges
Member Only Article
Wednesday
19 February, 2025
Quest Diagnostics has showcased remarkable resilience in a competitive landscape, achieving a 28.4% share growth and earning a Zacks Rank of #2. With a solid earnings yield and a history of exceeding expectations, can this healthcare leader continue to thrive amidst market challenges?
Article Impact Score
0
50
100
Underperform
Bearish
Neutral
Bullish
Outperform
0
Key Takeaways
- Loading...
Most Read
Join Foliko Premium!
Unlock the entire library of Foliko's Generative AI Investment Research. Plus, get AI powered trading signals and stock price predictions.
Go Premium - 7 Day Free Trial